Akebia Therapeutics Inc. buy SVB Leerink LLC
Start price
28.04.25
/
50%
€2.08
Target price
28.04.26
€6.16
Performance (%)
-38.53%
Price
09.01.26
€1.28
Summary
This prediction is currently active. The BUY prediction by SVB_Leerink_LLC for Akebia Therapeutics Inc. is performing very badly with a performance of -38.53%. This prediction currently runs until 28.04.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akebia Therapeutics Inc. | -3.321% | -3.321% |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $7.00 price target on the stock.
Ratings data for AKBA provided by MarketBeat